vs
Side-by-side financial comparison of CrowdStrike (CRWD) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.2× CrowdStrike). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -2.8%, a 7.2% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 22.2%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $314.1M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 20.8%).
CrowdStrike Holdings, Inc. is an American cybersecurity technology company based in Austin, Texas. It provides endpoint security, threat intelligence, and cyberattack response services.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
CRWD vs ONC — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $1.5B |
| Net Profit | $-34.0M | $66.5M |
| Gross Margin | 75.1% | 90.5% |
| Operating Margin | -5.6% | 12.4% |
| Net Margin | -2.8% | 4.4% |
| Revenue YoY | 22.2% | 32.8% |
| Net Profit YoY | -102.1% | 143.8% |
| EPS (diluted) | $-0.14 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.1B | $1.1B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $963.9M | $1.0B | ||
| Q2 24 | $921.0M | $929.2M | ||
| Q1 24 | $845.3M | $751.7M |
| Q4 25 | $-34.0M | $66.5M | ||
| Q3 25 | $-77.7M | $124.8M | ||
| Q2 25 | $-110.2M | $94.3M | ||
| Q1 25 | $-92.3M | $1.3M | ||
| Q4 24 | $-16.8M | $-151.9M | ||
| Q3 24 | $47.0M | $-121.3M | ||
| Q2 24 | $42.8M | $-120.4M | ||
| Q1 24 | $53.7M | $-251.2M |
| Q4 25 | 75.1% | 90.5% | ||
| Q3 25 | 73.5% | 86.1% | ||
| Q2 25 | 73.8% | 87.5% | ||
| Q1 25 | 74.1% | 85.2% | ||
| Q4 24 | 74.7% | 85.8% | ||
| Q3 24 | 75.4% | 83.0% | ||
| Q2 24 | 75.6% | 85.1% | ||
| Q1 24 | 75.3% | 83.4% |
| Q4 25 | -5.6% | 12.4% | ||
| Q3 25 | -9.7% | 11.5% | ||
| Q2 25 | -11.3% | 6.7% | ||
| Q1 25 | -8.1% | 1.0% | ||
| Q4 24 | -5.5% | -7.0% | ||
| Q3 24 | 1.4% | -12.0% | ||
| Q2 24 | 0.8% | -11.5% | ||
| Q1 24 | 3.5% | -34.8% |
| Q4 25 | -2.8% | 4.4% | ||
| Q3 25 | -6.6% | 8.8% | ||
| Q2 25 | -10.0% | 7.2% | ||
| Q1 25 | -8.7% | 0.1% | ||
| Q4 24 | -1.7% | -13.5% | ||
| Q3 24 | 4.9% | -12.1% | ||
| Q2 24 | 4.6% | -13.0% | ||
| Q1 24 | 6.4% | -33.4% |
| Q4 25 | $-0.14 | $0.05 | ||
| Q3 25 | $-0.31 | $0.08 | ||
| Q2 25 | $-0.44 | $0.06 | ||
| Q1 25 | $-0.37 | $0.00 | ||
| Q4 24 | $-0.07 | $-0.10 | ||
| Q3 24 | $0.19 | $-0.09 | ||
| Q2 24 | $0.17 | $-0.09 | ||
| Q1 24 | $0.23 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.8B | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $4.0B | $4.4B |
| Total Assets | $10.0B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.8B | $4.5B | ||
| Q3 25 | $5.0B | $4.0B | ||
| Q2 25 | $4.6B | $2.8B | ||
| Q1 25 | $4.3B | $2.5B | ||
| Q4 24 | $4.3B | $2.6B | ||
| Q3 24 | $4.0B | $2.7B | ||
| Q2 24 | $3.7B | $2.6B | ||
| Q1 24 | $3.5B | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $4.0B | $4.4B | ||
| Q3 25 | $3.8B | $4.1B | ||
| Q2 25 | $3.5B | $3.8B | ||
| Q1 25 | $3.3B | $3.5B | ||
| Q4 24 | $3.1B | $3.3B | ||
| Q3 24 | $2.9B | $3.4B | ||
| Q2 24 | $2.5B | $3.4B | ||
| Q1 24 | $2.3B | $3.4B |
| Q4 25 | $10.0B | $8.2B | ||
| Q3 25 | $9.3B | $7.6B | ||
| Q2 25 | $8.7B | $6.3B | ||
| Q1 25 | $8.7B | $5.8B | ||
| Q4 24 | $7.8B | $5.9B | ||
| Q3 24 | $7.2B | $5.8B | ||
| Q2 24 | $6.8B | $5.7B | ||
| Q1 24 | $6.6B | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $397.5M | $417.3M |
| Free Cash FlowOCF − Capex | $314.1M | $379.8M |
| FCF MarginFCF / Revenue | 25.5% | 25.4% |
| Capex IntensityCapex / Revenue | 6.8% | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2B | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $397.5M | $417.3M | ||
| Q3 25 | $332.8M | $402.6M | ||
| Q2 25 | $384.1M | $263.6M | ||
| Q1 25 | $345.7M | $44.1M | ||
| Q4 24 | $326.1M | $75.2M | ||
| Q3 24 | $326.6M | $188.4M | ||
| Q2 24 | $383.2M | $-95.6M | ||
| Q1 24 | $347.0M | $-308.6M |
| Q4 25 | $314.1M | $379.8M | ||
| Q3 25 | $302.3M | $354.5M | ||
| Q2 25 | $298.4M | $219.8M | ||
| Q1 25 | $258.5M | $-12.3M | ||
| Q4 24 | $247.4M | $-17.3M | ||
| Q3 24 | $287.4M | $54.7M | ||
| Q2 24 | $333.5M | $-205.5M | ||
| Q1 24 | $294.4M | $-465.1M |
| Q4 25 | 25.5% | 25.4% | ||
| Q3 25 | 25.9% | 25.1% | ||
| Q2 25 | 27.0% | 16.7% | ||
| Q1 25 | 24.4% | -1.1% | ||
| Q4 24 | 24.5% | -1.5% | ||
| Q3 24 | 29.8% | 5.5% | ||
| Q2 24 | 36.2% | -22.1% | ||
| Q1 24 | 34.8% | -61.9% |
| Q4 25 | 6.8% | 2.5% | ||
| Q3 25 | 2.6% | 3.4% | ||
| Q2 25 | 7.8% | 3.3% | ||
| Q1 25 | 8.2% | 5.0% | ||
| Q4 24 | 7.8% | 8.2% | ||
| Q3 24 | 4.1% | 13.3% | ||
| Q2 24 | 5.4% | 11.8% | ||
| Q1 24 | 6.2% | 20.8% |
| Q4 25 | — | 6.28× | ||
| Q3 25 | — | 3.22× | ||
| Q2 25 | — | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.95× | — | ||
| Q2 24 | 8.95× | — | ||
| Q1 24 | 6.46× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRWD
| Subscription And Circulation | $1.2B | 95% |
| Professional Services | $65.5M | 5% |
ONC
Segment breakdown not available.
